인기 연구 키워드 :
인기 활용 키워드 :

Receptor-guided 3D-Quantitative Structure?Activity Relationship and Docking Studies of 6-Substituted 2-Arylaminopurines as CDK2 Kinase Inhibitors

Seketoulie Keretsu Pavithra Kuruchi Balasubramanian Swapnil Pandurang Bhujbal 조승주 2017년

활용도
공유도
영향력

논문상세정보

- 저자 Seketoulie Keretsu Pavithra Kuruchi Balasubramanian Swapnil Pandurang Bhujbal 조승주
- 제어번호 105078479
- 학술지명 Bulletin of the Korean Chemical Society
- 권호사항 Vol. 38 No. 11 [ 2017 ]
- 발행처 대한화학회
- 자료유형 학술저널
- 수록면 1275-1284 ( 10쪽)
- 언어 English
- 출판년도 2017
- 등재정보 KCI등재
- 소장기관 성균관대학교 삼성학술정보관 성균관대학교 삼성학술정보관
- 판매처
- 참고문헌( 45)
유사주제 논문( 0)

인용/피인용

Receptor-guided 3D-Quantitative Structure?Activ ...

' Receptor-guided 3D-Quantitative Structure?Activity Relationship and Docking Studies of 6-Substituted 2-Arylaminopurines as CDK2 Kinase Inhibitors' 의 참고문헌

T. Otto Nat. Rev. Cancer 17 93- [2017]
L. Anders Cancer Cell 20 620- [2011]
M. Malumbres Nat. Rev. Cancer 9 153- [2009]
M. Malumbres Nat. Rev. Cancer 1 222- [2001]
M. Legraverend J. Med. Chem 43 1282- [2000]
S. K. Singh Curr. Cancer Ther. Rev 8 225- [2012]
J. Harper Chem. Rev 101 2511- [2001]
J. Bartek FEBS Lett 490 117- [2001]
U. Asghar Nat. Rev. Drug Discov 14 130- [2015]
C. Bruyère Curr. Opin. Cell Biol 25 772- [2013]
D. Horiuchi Proc. Natl. Acad. Sci. U. S. A 109 E1019- [2012]
L. Meijer Acc. Chem. Res 36 417- [2003]
A. Alexander Oncotarget 8 14897- [2017]
A. J. Deans Cancer Res 66 8219- [2006]
J. J. Molenaar Proc. Natl. Acad. Sci. U. S. A 106 12968- [2009]
G. Au-Yeung Clin. Cancer Res 23 1862- [2017]
L. Yang Oncotarget 6 20801- [2015]
A. M. Latham PLoS One 9 e110997- [2014]
C. R. Coxon J. Med. Chem 60 1746- [2017]
H. Sedlacek Int. J. Oncol 9 1143- [1996]
N. -A. Liu Proc. Natl. Acad. Sci. U. S. A 108 8414- [2011]
G. Feldmann Cancer Biol. Ther 12 598- [2011]
P. G. Wyatt J. Med. Chem 51 4986- [2008]
W. -G. Tong J. Clin. Oncol 28 3015- [2010]
D. Cirstea Leukemia 27 2366- [2013]
K. Goh Leukemia 26 236- [2012]
N. Raje Leukemia 23 961- [2009]
K. H. Oudah J. Am. Sci 13 4- [2017]
M. Arba Comput. Biol. Chem 67 9- [2017]
Y. Fang Sci. Rep 6 23634- [2016]
H. Kubinyi Drug Discov. Today 2 538- [1997]
P. Lan Bioorg. Med. Chem 20 6764- [2010]
S. Kumar Singh Med. Chem 3 75- [2007]
S. Singh Eur. J. Med. Chem 41 1310- [2006]
R. D. Cramer Mol. Inform 7 18- [1988]
G. Klebe J. Med. Chem 37 4130- [1994]
Y.-P. Li J. Mol. Graph. Model 41 61- [2013]
G. M. Morris J. Comput. Chem 19 1639- [1998]
R. Huey J. Comput. Chem 28 1145- [2007]
A. Echalier Chem. Biol 19 1028- [2012]
S. M. Green Trends Pharmacol. Sci 16 285- [1995]
R. Hu Bioorg. Med. Chem 17 2400- [2009]
D. J. Pratt J. Med. Chem 49 5470- [2006]
C. E. Arris J. Med. Chem 43 2797- [2000]
T. G. Davies Nat. Struct. Mol. Biol 9 745- [2002]

Receptor-guided 3D-Quantitative Structure?Activity Relationship and Docking Studies of 6-Substituted 2-Arylaminopurines as CDK2 Kinase Inhibitors

유사주제 논문( 0)

' Receptor-guided 3D-Quantitative Structure?Activity Relationship and Docking Studies of 6-Substituted 2-Arylaminopurines as CDK2 Kinase Inhibitors' 의 참고문헌

' Receptor-guided 3D-Quantitative Structure?Activity Relationship and Docking Studies of 6-Substituted 2-Arylaminopurines as CDK2 Kinase Inhibitors' 의 유사주제( ) 논문